Shree Ram Proteins Limited: Corrigendum & Addendum to AGM Notice and Annual Report 2024-25
Shree Ram Proteins Limited issued a corrigendum and addendum to its 17th AGM notice and Annual Report 2024-25. The AGM is on March 5, 2026. The corrigendum clarifies director reappointment for Mr. Piyush Vasoya. The FY 2024-25 results show zero revenue from operations and a loss after tax of ₹(2,107.51) Lakhs.
The announcement involves a correction to the AGM notice and includes the financial results for the fiscal year, which show a significant downturn. This information is material for investors and stakeholders.
The announcement is primarily a procedural update regarding the AGM notice and annual report, with a correction to a director's name. While the financial results presented show a negative performance, the announcement itself is neutral in tone and focuses on providing updated information.
Shree Ram Proteins Limited has issued a corrigendum and addendum to its 17th Annual General Meeting (AGM) notice and the Annual Report for the financial year 2024-25. The AGM is scheduled to be held on Thursday, March 05, 2026, at 2:00 p.m. through Video Conferencing / Other Audio Visual Means.
The corrigendum clarifies that Item No. 2 of the AGM notice, regarding the appointment of a director in place of Mr. Ravindra Kumar Singh who retires by rotation, should be read as concerning Mr. Piyush Vasoya, who also retires by rotation and offers himself for reappointment. Corresponding resolutions for Mr. Piyush Vasoya's reappointment are provided.
Additionally, there is an addendum to the Annual Report 2024-25, specifically concerning the Secretarial Audit Report for FY 2024-25, which was not included in the earlier intimation of the annual report. This corrigendum and addendum are now an integral part of the AGM Notice and Annual Report, and have been made available on the company's website and the NSE website.
The financial results for FY 2024-25 show a significant decrease in revenue from operations to zero, compared to ₹1,476.60 Lakhs in the previous year. The company reported a Loss Before Tax of ₹(2,101.19) Lakhs, resulting in a Loss After Tax of ₹(2,107.51) Lakhs for the current year, an increase from the previous year's loss of ₹(958.48) Lakhs. Directors have decided not to declare any dividend for FY 2024-25 to conserve profits for future purposes.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.